» Authors » Daniela Verzella

Daniela Verzella

Explore the profile of Daniela Verzella including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 1031
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vecchiotti D, Di Vito Nolfi M, Veglianti F, DallAglio F, Khan H, Flati I, et al.
Genes (Basel) . 2024 Nov; 15(11). PMID: 39596614
Bioprinting is an innovative technology in tissue engineering, enabling the creation of complex biological structures. This study aims to develop a three-dimensional (3D) bioprinted model of Müller cells (MCs) to...
2.
Vecchiotti D, Clementi L, Cornacchia E, Di Vito Nolfi M, Verzella D, Capece D, et al.
Cancers (Basel) . 2024 Sep; 16(18). PMID: 39335188
Prostate cancer (PCa), the most commonly diagnosed cancer in men worldwide, is particularly challenging for oncologists when a precise prognosis needs to be established. Indeed, the entire clinical management in...
3.
Cornice J, Verzella D, Arboretto P, Vecchiotti D, Capece D, Zazzeroni F, et al.
Genes (Basel) . 2024 Feb; 15(2). PMID: 38397187
Tumor-associated macrophages (TAMs) are the major component of the tumor microenvironment (TME), where they sustain tumor progression and or-tumor immunity. Due to their plasticity, macrophages can exhibit anti- or pro-tumor...
4.
Flati I, Di Vito Nolfi M, DallAglio F, Vecchiotti D, Verzella D, Alesse E, et al.
Genes (Basel) . 2023 Oct; 14(10). PMID: 37895302
Metabolism and the immunological state are intimately intertwined, as defense responses are bioenergetically expensive. Metabolic homeostasis is a key requirement for the proper function of immune cell subsets, and the...
5.
Verzella D, Cornice J, Arboretto P, Vecchiotti D, Di Vito Nolfi M, Capece D, et al.
Biomedicines . 2022 Sep; 10(9). PMID: 36140335
NF-κB transcription factors are major drivers of tumor initiation and progression. NF-κB signaling is constitutively activated by genetic alterations or environmental signals in many human cancers, where it contributes to...
6.
Capece D, Verzella D, Flati I, Arboretto P, Cornice J, Franzoso G
Trends Immunol . 2022 Aug; 43(9):757-775. PMID: 35965153
The procurement and management of nutrients and ability to fight infections are fundamental requirements for survival. These defense responses are bioenergetically costly, requiring the immune system to balance protection against...
7.
Di Francesco B, Verzella D, Capece D, Vecchiotti D, Di Vito Nolfi M, Flati I, et al.
Cancers (Basel) . 2022 Jul; 14(14). PMID: 35884618
Acute Myeloid Leukemia (AML) is an aggressive hematological malignancy that relies on highly heterogeneous cytogenetic alterations. Although in the last few years new agents have been developed for AML treatment,...
8.
Di Vito Nolfi M, Vecchiotti D, Flati I, Verzella D, Di Padova M, Alesse E, et al.
Front Oncol . 2022 Jul; 12:933922. PMID: 35814425
Drug resistance is a major impediment to patient survival and remains the primary cause of unsuccessful cancer therapy. Drug resistance occurs in many tumors and is frequently induced by chemotherapy...
9.
Vecchiotti D, Verzella D, Di Vito Nolfi M, DAndrea D, Flati I, Di Francesco B, et al.
Cells . 2022 Jul; 11(13). PMID: 35805202
Prostate cancer (PCa) is the second most frequent cancer in men worldwide. NF-κB seems to play a key role in cell survival, proliferation and invasion, sustaining the heterogeneous multifocal nature...
10.
Cornice J, Capece D, Di Vito Nolfi M, Di Padova M, Compagnoni C, Verzella D, et al.
Genes (Basel) . 2021 Nov; 12(11). PMID: 34828332
The detection of circulating microRNA (miRNA)-based biomarkers represents an innovative, non-invasive method for the early detection of cancer. However, the low concentration of miRNAs released in body fluids and the...